IPRIPR2021-00880Final Written Decision
Mylan Pharmaceuticals Inc. et al.v.Regeneron Pharmaceuticals, Inc.
IPR challenge of US 9669069.
Type
IPR
Filed
May 5, 2021
Instituted
Nov 10, 2021
Decided
Jul 19, 2024
Patent
Application
14972560
Inventor
George D. YANCOPOULOS
Granted
Jun 6, 2017
01
Timeline
3 milestones
2021-05-05Petition filed
2021-11-10Institution
2022-11-09Terminated
02
Parties & counsel
Petitioner
Mylan Pharmaceuticals Inc. et al.
Counsel
Molino, Paulet al
Patent Owner
Regeneron Pharmaceuticals, Inc.
Counsel
Fishman, Deborahet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →